Silence Therapeutics (SLN) Cash & Current Investments: 2019-2025
Historic Cash & Current Investments for Silence Therapeutics (SLN) over the last 6 years, with Sep 2025 value amounting to $122.4 million.
- Silence Therapeutics' Cash & Current Investments rose 52.01% to $122.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $664.5 million, marking a year-over-year increase of 42.02%. This contributed to the annual value of $147.3 million for FY2024, which is 39.31% up from last year.
- As of Q3 2025, Silence Therapeutics' Cash & Current Investments stood at $122.4 million, which was down 34.43% from $186.6 million recorded in Q2 2025.
- Silence Therapeutics' Cash & Current Investments' 5-year high stood at $208.1 million during Q1 2025, with a 5-year trough of $37.5 million in Q1 2021.
- For the 3-year period, Silence Therapeutics' Cash & Current Investments averaged around $121.5 million, with its median value being $122.4 million (2025).
- Per our database at Business Quant, Silence Therapeutics' Cash & Current Investments spiked by 215.61% in 2021 and then tumbled by 35.14% in 2022.
- Over the past 5 years, Silence Therapeutics' Cash & Current Investments (Quarterly) stood at $99.1 million in 2021, then crashed by 35.14% to $64.3 million in 2022, then surged by 64.49% to $105.8 million in 2023, then skyrocketed by 39.31% to $147.3 million in 2024, then soared by 52.01% to $122.4 million in 2025.
- Its Cash & Current Investments was $122.4 million in Q3 2025, compared to $186.6 million in Q2 2025 and $208.1 million in Q1 2025.